Citation: Sj. Mather et G. Westera, Education in radiopharmacy and radiopharmaceutical chemistry: recent developments, EUR J NUCL, 28(3), 2001, pp. BP48-BP50
Authors:
Spang, JE
Bertrand, S
Westera, G
Patt, JT
Schubiger, PA
Bertrand, D
Citation: Je. Spang et al., Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptors, CHEM BIOL, 7(7), 2000, pp. 545-555
Authors:
Spang, JE
Patt, JT
Westera, G
Schubiger, PA
Citation: Je. Spang et al., Comparison of N-[C-11]methyl-norchloroepibatidine and N-[C-11]methyl-2-(2-pyridyl)-7-azabicyclo[2.2.1]heptane with N-[C-11]methyl-epibatidine in small animal PET studies, NUCL MED BI, 27(3), 2000, pp. 239-247
Authors:
Millet, P
Graf, C
Buck, A
Walder, B
Westera, G
Broggini, W
Arigoni, M
Slosman, D
Bouras, C
Ibanez, V
Citation: P. Millet et al., Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors, J CEREBR B, 20(11), 2000, pp. 1587-1603
Authors:
Patt, JT
Spang, JE
Westera, G
Buck, A
Schubiger, PA
Citation: Jt. Patt et al., Synthesis and in vivo studies of [C-11]N-methylepibatidine: Comparison of the stereoisomers, NUCL MED BI, 26(2), 1999, pp. 165-173
Authors:
Spang, JE
Patt, JT
Westera, G
Schubiger, PA
Citation: Je. Spang et al., Synthesis and [C-11]-radiolabelling of dechloro-epibatidine and 2PABH, twopotential radioligands for studying the central nAChRs in vivo., J LABEL C R, 42(8), 1999, pp. 761-771
Citation: G. Westera et al., Postgraduate education of persons responsible for the small-scale production and quality control of radiopharmaceuticals (radiopharmaceutical chemists, radiopharmacists): current status, EUR J NUCL, 26(3), 1999, pp. BP8-BP9